Feature Channels: Kidney Disease

Filters close
22-May-2020 12:25 PM EDT
Inequities in Access to Kidney Transplantation Exist Even with Universal Healthcare
American Society of Nephrology (ASN)

• In a study of patients with newly diagnosed kidney failure at 71 kidney centers in the UK, older age, additional illnesses, obesity, and lower socioeconomic status were associated with a lower likelihood of being put on transplant waiting list.

Released: 28-May-2020 2:20 PM EDT
Kidney Health Initiative Urges the Acceleration of Home Therapy Technology in Response to Coronavirus 2019 (Covid-19)
American Society of Nephrology (ASN)

The COVID-19 pandemic highlights the vulnerability of people with kidney failure who rely on in-center hemodialysis. People with kidney failure are at high risk of severe COVID-19 complications and are exposed to infection due to a kidney replacement therapy process that requires traveling to a dialysis facility multiple times a week.

access_time Embargo lifts in 2 days
Embargo will expire: 29-May-2020 11:00 AM EDT Released to reporters: 28-May-2020 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-May-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Novel targeted drug induced positive response for patients with von Hippel-Lindau disease–associated kidney cancer
Released: 28-May-2020 10:15 AM EDT
Novel targeted drug induced positive response for patients with von Hippel-Lindau disease–associated kidney cancer
University of Texas M. D. Anderson Cancer Center

In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor (HIF)-2a was well tolerated and resulted in clinical responses for patients with von Hippel-Lindau disease (VHL)–associated renal cell carcinoma (RCC).

Newswise:Video Embedded new-urine-testing-method-holds-promise-for-kidney-stone-sufferers
Released: 27-May-2020 1:30 PM EDT
New urine testing method holds promise for kidney stone sufferers
Penn State College of Engineering

An improved urine-testing system for people suffering from kidney stones inspired by nature and proposed by researchers from Penn State and Stanford University may enable patients to receive results within 30 minutes instead of the current turnaround time of a week or more.

20-May-2020 10:55 AM EDT
Sedative Drug in Combination with Opioids May Be Especially Dangerous
American Society of Nephrology (ASN)

• In an analysis of information on US adults initiating hemodialysis, 16% of patients were dispensed a short-acting benzodiazepine, and approximately one-quarter of these patients were also dispensed opioids. • Among patients with an opioid prescription, being dispensed a short-acting benzodiazepine had a 1.9-fold higher risk of dying over a median follow-up of 16 months compared with patients without a short-acting benzodiazepine.

15-May-2020 9:00 AM EDT
Certain Environmental Chemicals Linked with Poor Kidney Health
American Society of Nephrology (ASN)

• In an analysis of blood and urine samples from 46,748 US adults, elevated levels of 7 environmental chemicals were associated with markers of kidney disease.

Newswise: Measuring Blood Damage
Released: 21-May-2020 12:05 PM EDT
Measuring Blood Damage
University of Delaware

Red blood cells sometimes rupture when blood is sent through faulty equipment, such as a dialysis machine. This is called hemolysis. Hemolysis also can occur during blood work when blood is drawn too quickly through a needle, leading to defective laboratory samples. University of Delaware mechanical engineer Tyler Van Buren and collaborating colleagues at Princeton University have developed a method to monitor blood damage in real-time.

Released: 20-May-2020 10:35 AM EDT
New Liver Cancer Research Targets Non-Cancer Cells to Blunt Tumor Growth
Perelman School of Medicine at the University of Pennsylvania

“Senotherapy,” a treatment that uses small molecule drugs to target “senescent” cells, or those cells that no longer undergo cell division, blunts liver tumor progression in animal models according to new research from a team led by Celeste Simon, PhD, a professor of Cell and Developmental Biology in the Perelman School of Medicine at the University of Pennsylvania and scientific director of the Abramson Family Cancer Research Institute. The study was published in Nature Cell Biology.

Newswise: Story Tips from Johns Hopkins Experts on COVID-19
Released: 19-May-2020 8:55 AM EDT
Story Tips from Johns Hopkins Experts on COVID-19
Johns Hopkins Medicine

It seems like there will never be enough “thank you’s” for the incredible doctors, nurses technicians and support staff members who are working around the clock to help patients with this dangerous disease. It is their dedication, determination and spirit that allow Johns Hopkins to deliver the promise of medicine.

Showing results

110 of 10